ENALAPRIL

ENALAPRIL was reported 55726 times

ENALAPRIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CLEAR CELL RENAL CELL CARCINOMA 54 0.0776
1 LOSS OF EMPLOYMENT 113 0.0374
2 CARDIOACTIVE DRUG LEVEL INCREASED 48 0.0365
3 ATRIOVENTRICULAR BLOCK COMPLETE 210 0.0313
4 CONCOMITANT DISEASE PROGRESSION 61 0.0312
5 HYPERKALAEMIA 1094 0.0312
6 VASCULAR STENT THROMBOSIS 60 0.0295
7 ANGIONEUROTIC OEDEMA 73 0.0274
8 THERAPEUTIC AGENT TOXICITY 88 0.0264
9 NEPHROGENIC ANAEMIA 122 0.0263
10 GINGIVAL HYPERTROPHY 37 0.0244
11 BRADYARRHYTHMIA 40 0.0243
12 CARDIAC FAILURE CHRONIC 103 0.0241
13 LEFT VENTRICULAR HYPERTROPHY 100 0.0233
14 TONGUE OEDEMA 89 0.0233
15 VENOUS OCCLUSION 42 0.0231
16 ORTHOPNOEA 72 0.0226
17 HYPERTENSIVE HEART DISEASE 41 0.0219
18 RENAL FAILURE ACUTE 925 0.0218
19 LYMPHOPROLIFERATIVE DISORDER 61 0.0207
20 HYPERTENSIVE CRISIS 220 0.0198
21 BUNDLE BRANCH BLOCK LEFT 83 0.0196
22 HYPERPARATHYROIDISM SECONDARY 49 0.0195
23 DILATATION VENTRICULAR 41 0.0195
24 HYPOVOLAEMIC SHOCK 91 0.0190
25 VENTRICULAR HYPERTROPHY 47 0.0187
26 PANCREATITIS NECROTISING 43 0.0187
27 DIABETIC RETINOPATHY 63 0.0185
28 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 189 0.0184
29 ISCHAEMIC CARDIOMYOPATHY 56 0.0182
30 BLOOD UREA INCREASED 305 0.0182
31 REBOUND ACID HYPERSECRETION 55 0.0182
32 CARDIOMEGALY 219 0.0178
33 ANGINA UNSTABLE 113 0.0174
34 DIABETIC NEPHROPATHY 38 0.0172
35 AORTIC VALVE INCOMPETENCE 73 0.0171
36 HYPOVOLAEMIA 98 0.0167
37 RENAL FAILURE CHRONIC 128 0.0166
38 NEPHROTIC SYNDROME 114 0.0166
39 HAEMORRHAGIC ANAEMIA 73 0.0166
40 LEFT VENTRICULAR FAILURE 57 0.0165
41 CARDIAC FAILURE ACUTE 110 0.0165
42 BLOOD PRESSURE INADEQUATELY CONTROLLED 98 0.0163
43 OSTEITIS 41 0.0162
44 ANGIOEDEMA 718 0.0162
45 HEPATIC STEATOSIS 300 0.0161
46 HYPOGLYCAEMIC COMA 46 0.0159
47 HYPONATRAEMIA 897 0.0159
48 BLOOD CHLORIDE DECREASED 41 0.0159
49 BRAIN NATRIURETIC PEPTIDE INCREASED 49 0.0159
50 LACTIC ACIDOSIS 514 0.0159
51 VENTRICULAR DYSFUNCTION 41 0.0158
52 INFARCTION 108 0.0158
53 BRONCHOPNEUMONIA 54 0.0158
54 DENGUE FEVER 36 0.0157
55 ANURIA 134 0.0156
56 VENTRICULAR HYPOKINESIA 50 0.0156
57 DIABETIC NEUROPATHY 77 0.0155
58 AZOTAEMIA 62 0.0155
59 LACUNAR INFARCTION 37 0.0154
60 DRUG INTERACTION 2409 0.0152
61 CAROTID ARTERY STENOSIS 53 0.0152
62 HEPATITIS CHOLESTATIC 90 0.0149
63 BUNDLE BRANCH BLOCK RIGHT 67 0.0146
64 SKIN HYPERTROPHY 41 0.0146
65 MITRAL VALVE INCOMPETENCE 165 0.0146
66 ATRIOVENTRICULAR BLOCK SECOND DEGREE 44 0.0145
67 HYPOGLYCAEMIA 699 0.0144
68 CARDIOPULMONARY FAILURE 56 0.0143
69 ATRIOVENTRICULAR BLOCK FIRST DEGREE 62 0.0143
70 CONGESTIVE CARDIOMYOPATHY 59 0.0141
71 AORTIC ARTERIOSCLEROSIS 36 0.0140
72 ACUTE KIDNEY INJURY 2126 0.0139
73 END STAGE RENAL DISEASE 250 0.0137
74 CARDIAC FAILURE 1094 0.0136
75 OLIGURIA 84 0.0135
76 BRADYPHRENIA 88 0.0135
77 ARTERIOSCLEROSIS CORONARY ARTERY 89 0.0134
78 HAEMODIALYSIS 112 0.0133
79 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 68 0.0133
80 NEPHROGENIC SYSTEMIC FIBROSIS 40 0.0132
81 UPPER GASTROINTESTINAL HAEMORRHAGE 222 0.0132
82 DYSLIPIDAEMIA 67 0.0132
83 URINE OUTPUT DECREASED 115 0.0131
84 BLOOD CREATINE INCREASED 58 0.0131
85 TRICUSPID VALVE INCOMPETENCE 104 0.0131
86 ACUTE MYOCARDIAL INFARCTION 386 0.0131
87 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 43 0.0130
88 ATRIOVENTRICULAR BLOCK 99 0.0128
89 ERYSIPELAS 64 0.0127
90 LEFT VENTRICULAR DYSFUNCTION 85 0.0127
91 METABOLIC ENCEPHALOPATHY 38 0.0126
92 AORTIC STENOSIS 44 0.0126
93 CARDIAC DYSFUNCTION 47 0.0126
94 INTERNATIONAL NORMALISED RATIO DECREASED 51 0.0126
95 CUTANEOUS VASCULITIS 45 0.0123
96 BLOOD CREATININE INCREASED 801 0.0123
97 GASTRITIS EROSIVE 57 0.0122
98 CORONARY ARTERY STENOSIS 61 0.0121
99 CARDIOGENIC SHOCK 173 0.0120
100 RALES 70 0.0120
101 LOWER GASTROINTESTINAL HAEMORRHAGE 88 0.0119
102 BLOOD PRESSURE SYSTOLIC DECREASED 54 0.0119
103 ELECTROCARDIOGRAM ABNORMAL 93 0.0118
104 SINUS BRADYCARDIA 114 0.0118
105 CEREBRAL ATROPHY 47 0.0118
106 PANCREATITIS ACUTE 265 0.0118
107 BLOOD URIC ACID INCREASED 68 0.0118
108 BRADYCARDIA 615 0.0116
109 ACUTE CORONARY SYNDROME 96 0.0116
110 PROTHROMBIN TIME PROLONGED 69 0.0115
111 GASTROENTERITIS 168 0.0115
112 CEREBRAL ISCHAEMIA 59 0.0115
113 MUSCLE HAEMORRHAGE 46 0.0115
114 CIRCULATORY COLLAPSE 195 0.0114
115 METABOLIC ACIDOSIS 366 0.0114
116 CARDIAC MURMUR 99 0.0114
117 HYPERURICAEMIA 47 0.0114
118 RENAL TUBULAR NECROSIS 112 0.0114
119 CORONARY ARTERY DISEASE 344 0.0113
120 WOUND HAEMORRHAGE 42 0.0113
121 MYOPATHY 98 0.0113
122 MYOCARDIAL ISCHAEMIA 129 0.0113
123 MELAENA 249 0.0113
124 PROTEINURIA 215 0.0113
125 BLOOD POTASSIUM INCREASED 183 0.0113
126 PEMPHIGOID 85 0.0113
127 KIDNEY TRANSPLANT REJECTION 54 0.0112
128 ACIDOSIS 86 0.0112
129 CREATININE RENAL CLEARANCE DECREASED 45 0.0112
130 TOXIC EPIDERMAL NECROLYSIS 170 0.0112
131 INTERNATIONAL NORMALISED RATIO INCREASED 318 0.0111
132 IRON DEFICIENCY 50 0.0111
133 ENDOCARDITIS 57 0.0111
134 CARDIAC FAILURE CONGESTIVE 891 0.0111
135 ACUTE PULMONARY OEDEMA 62 0.0110
136 DIABETES MELLITUS INADEQUATE CONTROL 195 0.0110
137 CEREBRAL HAEMATOMA 37 0.0110
138 VENTRICULAR TACHYCARDIA 179 0.0108
139 NECROSIS 60 0.0108
140 HYPOMAGNESAEMIA 148 0.0106
141 CHOLECYSTITIS ACUTE 60 0.0106
142 CHRONIC KIDNEY DISEASE 804 0.0106
143 TUBULOINTERSTITIAL NEPHRITIS 198 0.0106
144 ARTERIAL OCCLUSIVE DISEASE 83 0.0105
145 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 43 0.0105
146 RENAL FAILURE 1398 0.0105
147 MULTIPLE INJURIES 66 0.0105
148 PERIPHERAL VASCULAR DISORDER 54 0.0105
149 BLOOD LACTIC ACID INCREASED 55 0.0104
150 ASTHMATIC CRISIS 38 0.0104
151 ATRIAL FLUTTER 83 0.0104
152 HYPERGLYCAEMIA 375 0.0103
153 LEUKOCYTOSIS 185 0.0102
154 STAPHYLOCOCCAL BACTERAEMIA 44 0.0101
155 TACHYPNOEA 136 0.0100
156 RHABDOMYOLYSIS 416 0.0100
157 RENAL CYST 79 0.0099
158 DUODENAL ULCER 70 0.0099
159 VENTRICULAR EXTRASYSTOLES 103 0.0099
160 RENAL INJURY 292 0.0098
161 RENAL CELL CARCINOMA 48 0.0098
162 INTESTINAL ISCHAEMIA 54 0.0098
163 ISCHAEMIA 45 0.0098
164 BLOOD PRESSURE DIASTOLIC DECREASED 72 0.0097
165 LARYNGEAL OEDEMA 60 0.0097
166 SUDDEN DEATH 103 0.0097
167 SPINAL PAIN 114 0.0097
168 HAEMATOCRIT DECREASED 192 0.0097
169 ISCHAEMIC STROKE 172 0.0096
170 HYPOKALAEMIA 444 0.0096
171 MULTI-ORGAN FAILURE 166 0.0096
172 HYPOTHERMIA 97 0.0096
173 CARDIOMYOPATHY 141 0.0095
174 ARTERIOSCLEROSIS 89 0.0094
175 ANGINA PECTORIS 270 0.0094
176 RENAL IMPAIRMENT 791 0.0094
177 NEPHROPATHY 87 0.0093
178 ATELECTASIS 89 0.0092
179 ELECTROLYTE IMBALANCE 107 0.0092
180 HYPERLIPIDAEMIA 110 0.0092
181 CORONARY ARTERY OCCLUSION 126 0.0092
182 SYNCOPE 918 0.0092
183 POLYURIA 75 0.0091
184 DIVERTICULUM INTESTINAL 40 0.0091
185 HYPOALBUMINAEMIA 71 0.0091
186 VARICOSE VEIN 47 0.0091
187 RIGHT VENTRICULAR FAILURE 63 0.0090
188 PULMONARY HYPERTENSION 187 0.0090
189 GENERALISED OEDEMA 111 0.0090
190 BLOOD PRESSURE DECREASED 592 0.0089
191 IRON DEFICIENCY ANAEMIA 82 0.0089
192 SPINAL OSTEOARTHRITIS 78 0.0089
193 GASTRIC ULCER HAEMORRHAGE 49 0.0088
194 HAEMORRHAGIC STROKE 69 0.0088
195 PULMONARY CONGESTION 116 0.0088
196 PULMONARY OEDEMA 394 0.0088
197 HYPOTENSION 1763 0.0088
198 BLOOD SODIUM DECREASED 164 0.0087
199 CHOLESTASIS 167 0.0087
200 GAMMA-GLUTAMYLTRANSFERASE INCREASED 192 0.0087
201 VENTRICULAR FIBRILLATION 96 0.0086
202 HAEMATOMA 223 0.0086
203 CARDIAC VALVE DISEASE 49 0.0086
204 HEPATOMEGALY 84 0.0085
205 COLITIS ISCHAEMIC 57 0.0084
206 SWOLLEN TONGUE 263 0.0084
207 DERMATITIS EXFOLIATIVE 42 0.0084
208 ECONOMIC PROBLEM 127 0.0084
209 CHOLELITHIASIS 274 0.0083
210 RESPIRATORY RATE INCREASED 74 0.0083
211 POSTOPERATIVE WOUND INFECTION 56 0.0083
212 ENTEROCOCCAL INFECTION 40 0.0083
213 HYPOCALCAEMIA 156 0.0082
214 UROSEPSIS 76 0.0082
215 GASTRITIS 216 0.0082
216 CARDIAC TAMPONADE 39 0.0082
217 ARRHYTHMIA 387 0.0082
218 CACHEXIA 42 0.0082
219 HYPERTENSION 1728 0.0081
220 LUNG INFILTRATION 72 0.0081
221 TROPONIN INCREASED 62 0.0081
222 BLOOD LACTATE DEHYDROGENASE INCREASED 129 0.0081
223 OBSTRUCTIVE AIRWAYS DISORDER 90 0.0081
224 EJECTION FRACTION DECREASED 125 0.0080
225 ORTHOSTATIC HYPOTENSION 140 0.0080
226 HEMIPARESIS 136 0.0080
227 HYPERNATRAEMIA 40 0.0080
228 NEPHROPATHY TOXIC 90 0.0080
229 ANOREXIA 103 0.0080
230 HAEMATURIA 273 0.0080
231 BRADYKINESIA 47 0.0080
232 ATRIAL FIBRILLATION 774 0.0079
233 BENIGN PROSTATIC HYPERPLASIA 41 0.0079
234 CONCOMITANT DISEASE AGGRAVATED 49 0.0079
235 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 40 0.0079
236 INGUINAL HERNIA 48 0.0079
237 CARDIAC PACEMAKER INSERTION 47 0.0079
238 DIVERTICULUM 56 0.0079
239 ANGIOPATHY 44 0.0078
240 DEHYDRATION 1045 0.0078
241 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 69 0.0078
242 GASTRIC ULCER 148 0.0078
243 CEREBRAL INFARCTION 190 0.0078
244 BLOOD ALKALINE PHOSPHATASE INCREASED 191 0.0077
245 DIABETES MELLITUS 585 0.0077
246 SHOCK 175 0.0076
247 POLYNEUROPATHY 91 0.0076
248 DISORIENTATION 301 0.0076
249 EXTRASYSTOLES 53 0.0076
250 ECCHYMOSIS 52 0.0076
251 STRESS CARDIOMYOPATHY 44 0.0076
252 CONTRAINDICATED PRODUCT ADMINISTERED 229 0.0076
253 HYPERCHOLESTEROLAEMIA 73 0.0076
254 RESPIRATORY FAILURE 548 0.0075
255 KLEBSIELLA INFECTION 38 0.0075
256 CYANOSIS 118 0.0075
257 COAGULOPATHY 125 0.0075
258 NOCTURIA 91 0.0075
259 LIPASE INCREASED 57 0.0074
260 BLOOD CREATINE PHOSPHOKINASE INCREASED 214 0.0074
261 OEDEMA PERIPHERAL 905 0.0074
262 ANAEMIA 1409 0.0074
263 DEPRESSED LEVEL OF CONSCIOUSNESS 292 0.0074
264 REFUSAL OF TREATMENT BY PATIENT 48 0.0073
265 HAEMODYNAMIC INSTABILITY 56 0.0073
266 TOXIC SKIN ERUPTION 74 0.0073
267 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 70 0.0073
268 EXERCISE TOLERANCE DECREASED 42 0.0073
269 MYOCLONUS 87 0.0073
270 SUBARACHNOID HAEMORRHAGE 74 0.0073
271 BLOOD TRIGLYCERIDES INCREASED 128 0.0072
272 VITAMIN D DEFICIENCY 70 0.0072
273 RESPIRATORY DISTRESS 198 0.0072
274 FACE OEDEMA 120 0.0071
275 ASPHYXIA 58 0.0071
276 GLUCOSE TOLERANCE IMPAIRED 42 0.0071
277 SOPOR 94 0.0071
278 GOUT 127 0.0071
279 TRANSIENT ISCHAEMIC ATTACK 238 0.0070
280 BLOOD PRESSURE INCREASED 1077 0.0070
281 EMPHYSEMA 71 0.0070
282 PHARYNGEAL OEDEMA 108 0.0070
283 HEPATOTOXICITY 156 0.0070
284 HAEMATEMESIS 177 0.0070
285 RETINAL DETACHMENT 64 0.0070
286 SEROTONIN SYNDROME 133 0.0069
287 PLEURISY 41 0.0069
288 PLATELET COUNT INCREASED 90 0.0069
289 METABOLIC DISORDER 40 0.0069
290 PRODUCT SUPPLY ISSUE 49 0.0069
291 BLOOD PRESSURE ABNORMAL 136 0.0068
292 CARDIO-RESPIRATORY ARREST 286 0.0068
293 HIATUS HERNIA 88 0.0068
294 RESPIRATORY TRACT INFECTION 177 0.0068
295 SUBDURAL HAEMATOMA 97 0.0068
296 GLOMERULAR FILTRATION RATE DECREASED 83 0.0067
297 HYPERKERATOSIS 37 0.0067
298 AORTIC ANEURYSM 51 0.0067
299 PERONEAL NERVE PALSY 38 0.0067
300 BLOOD ALBUMIN DECREASED 53 0.0067
301 CARDIAC ARREST 551 0.0067
302 BLOOD GLUCOSE FLUCTUATION 73 0.0067
303 SPINAL DISORDER 63 0.0066
304 TENDON RUPTURE 82 0.0066
305 BODY HEIGHT DECREASED 71 0.0066
306 SHOCK HAEMORRHAGIC 54 0.0066
307 PLEURAL EFFUSION 403 0.0066
308 DISSEMINATED INTRAVASCULAR COAGULATION 93 0.0066
309 HERPES VIRUS INFECTION 38 0.0066
310 SKIN ULCER 170 0.0066
311 GASTROINTESTINAL HAEMORRHAGE 549 0.0066
312 URINARY RETENTION 219 0.0066
313 DIALYSIS 93 0.0065
314 CHOKING SENSATION 36 0.0065
315 METASTASES TO BONE 107 0.0065
316 PETECHIAE 68 0.0065
317 SUPRAVENTRICULAR TACHYCARDIA 62 0.0065
318 OSTEOMYELITIS 117 0.0065
319 HYPOPHAGIA 165 0.0064
320 KETOACIDOSIS 48 0.0064
321 BRAIN OEDEMA 81 0.0064
322 BRONCHOSPASM 91 0.0064
323 HYPERBILIRUBINAEMIA 66 0.0064
324 INTERVERTEBRAL DISC PROTRUSION 139 0.0064
325 ANAL INCONTINENCE 57 0.0063
326 BLOOD GLUCOSE ABNORMAL 117 0.0063
327 HYPERTRIGLYCERIDAEMIA 37 0.0063
328 SEPTIC SHOCK 275 0.0063
329 DECREASED IMMUNE RESPONSIVENESS 62 0.0063
330 HYPERTHERMIA 48 0.0063
331 OSTEOARTHRITIS 264 0.0062
332 DYSPNOEA EXERTIONAL 234 0.0062
333 ACUTE RESPIRATORY FAILURE 119 0.0062
334 MOTOR DYSFUNCTION 63 0.0062
335 C-REACTIVE PROTEIN INCREASED 224 0.0062
336 GASTROINTESTINAL INFECTION 55 0.0061
337 NODULE 80 0.0061
338 PRESYNCOPE 149 0.0061
339 ENTERITIS 39 0.0061
340 MYOCARDIAL INFARCTION 1061 0.0061
341 HYPOXIA 214 0.0061
342 MULTIPLE ORGAN DYSFUNCTION SYNDROME 172 0.0061
343 SPINAL COMPRESSION FRACTURE 50 0.0060
344 ASPARTATE AMINOTRANSFERASE INCREASED 321 0.0060
345 APNOEA 47 0.0060
346 PROCEDURAL COMPLICATION 46 0.0060
347 HAEMOGLOBIN DECREASED 616 0.0060
348 ACUTE RESPIRATORY DISTRESS SYNDROME 106 0.0060
349 CEREBRAL HAEMORRHAGE 214 0.0060
350 PULMONARY MASS 89 0.0060
351 GANGRENE 36 0.0060
352 SLEEP APNOEA SYNDROME 114 0.0060
353 BLOOD CHOLESTEROL INCREASED 278 0.0060
354 BLOOD PRESSURE SYSTOLIC INCREASED 116 0.0059
355 HYPOTHYROIDISM 189 0.0059
356 RETINAL HAEMORRHAGE 42 0.0059
357 MICTURITION URGENCY 67 0.0059
358 DEVICE RELATED INFECTION 90 0.0058
359 PERIPHERAL COLDNESS 80 0.0058
360 SPEECH DISORDER 305 0.0058
361 GLAUCOMA 112 0.0058
362 ATAXIA 69 0.0058
363 CHOLECYSTITIS 69 0.0058
364 DYSARTHRIA 218 0.0058
365 ACUTE HEPATIC FAILURE 79 0.0058
366 PNEUMONIA BACTERIAL 53 0.0058
367 BASAL CELL CARCINOMA 90 0.0058
368 LIVER DISORDER 255 0.0057
369 HEPATIC FAILURE 173 0.0057
370 BACTERIAL INFECTION 107 0.0057
371 DRUG TOXICITY 78 0.0057
372 DELIRIUM 198 0.0057
373 PNEUMONIA ASPIRATION 142 0.0057
374 ASCITES 167 0.0057
375 DRUG LEVEL INCREASED 94 0.0057
376 OESOPHAGITIS 62 0.0057
377 FEAR 152 0.0056
378 GINGIVAL BLEEDING 77 0.0056
379 EYE HAEMORRHAGE 75 0.0056
380 HAEMORRHAGE INTRACRANIAL 84 0.0056
381 BLOOD CALCIUM DECREASED 63 0.0056
382 ANHEDONIA 147 0.0056
383 OEDEMA 303 0.0056
384 CONFUSIONAL STATE 902 0.0056
385 EPISTAXIS 415 0.0055
386 SENSORY DISTURBANCE 89 0.0055
387 PYELONEPHRITIS 48 0.0055
388 DIABETIC KETOACIDOSIS 133 0.0055
389 HEMIPLEGIA 46 0.0055
390 GLYCOSYLATED HAEMOGLOBIN INCREASED 139 0.0055
391 PANCREATITIS 291 0.0055
392 ELECTROCARDIOGRAM QT PROLONGED 198 0.0055
393 CHEST PAIN 1019 0.0055
394 URINARY INCONTINENCE 163 0.0055
395 BLOOD PRESSURE FLUCTUATION 132 0.0055
396 ALTERED STATE OF CONSCIOUSNESS 119 0.0055
397 GENERAL PHYSICAL HEALTH DETERIORATION 634 0.0055
398 RENAL DISORDER 255 0.0055
399 OBESITY 87 0.0055
400 DIARRHOEA HAEMORRHAGIC 51 0.0055
401 PERICARDIAL EFFUSION 126 0.0054
402 HYPERCALCAEMIA 67 0.0054
403 COMA 258 0.0054
404 CELLULITIS 273 0.0054
405 DYSURIA 199 0.0054
406 DECUBITUS ULCER 44 0.0054
407 TRANSAMINASES INCREASED 120 0.0054
408 BODY TEMPERATURE DECREASED 53 0.0054
409 DYSSTASIA 157 0.0054
410 TYPE 2 DIABETES MELLITUS 181 0.0054
411 PULMONARY HAEMORRHAGE 42 0.0054
412 TRANSPLANT REJECTION 43 0.0054
413 MALNUTRITION 60 0.0054
414 TACHYCARDIA 475 0.0053
415 HYDRONEPHROSIS 40 0.0053
416 ALANINE AMINOTRANSFERASE INCREASED 328 0.0053
417 HEAD INJURY 169 0.0053
418 LARGE INTESTINE PERFORATION 37 0.0053
419 VASCULITIS 62 0.0053
420 MOUTH HAEMORRHAGE 39 0.0053
421 BLINDNESS UNILATERAL 75 0.0053
422 NEUROLEPTIC MALIGNANT SYNDROME 63 0.0053
423 PURPURA 47 0.0053
424 HYPOTONIA 53 0.0053
425 SPLENOMEGALY 62 0.0053
426 AGEUSIA 132 0.0053
427 RECTAL HAEMORRHAGE 227 0.0053
428 PELVIC FRACTURE 41 0.0053
429 BLOOD BILIRUBIN INCREASED 142 0.0053
430 EXOSTOSIS 48 0.0053
431 PSEUDOMONAS INFECTION 45 0.0052
432 MUSCULAR WEAKNESS 596 0.0052
433 RED BLOOD CELL SEDIMENTATION RATE INCREASED 58 0.0052
434 HEPATITIS 134 0.0052
435 IMMUNODEFICIENCY 78 0.0052
436 PALLOR 142 0.0052
437 EATING DISORDER 111 0.0052
438 RHINITIS 42 0.0052
439 GRAND MAL CONVULSION 48 0.0052
440 DRUG-INDUCED LIVER INJURY 163 0.0052
441 THYROID DISORDER 80 0.0052
442 WHITE BLOOD CELL COUNT INCREASED 198 0.0052
443 PHARYNGITIS 64 0.0052
444 MENTAL STATUS CHANGES 143 0.0051
445 ERYTHEMA MULTIFORME 48 0.0051
446 APATHY 75 0.0051
447 ERECTILE DYSFUNCTION 132 0.0051
448 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 268 0.0051
449 PARKINSONISM 50 0.0051
450 BLOOD DISORDER 41 0.0051
451 AGRANULOCYTOSIS 95 0.0051
452 ORAL DISCOMFORT 71 0.0051
453 HYPOKINESIA 74 0.0051
454 FLUID RETENTION 259 0.0051
455 OXYGEN SATURATION DECREASED 284 0.0050
456 CATARACT 300 0.0050
457 HAEMOLYTIC ANAEMIA 45 0.0050
458 HAEMOPTYSIS 140 0.0050
459 ABASIA 124 0.0050
460 LEUKOPENIA 251 0.0050
461 JAUNDICE 135 0.0050
462 FLANK PAIN 47 0.0050
463 URINARY TRACT INFECTION 855 0.0050
464 FEMUR FRACTURE 155 0.0050
465 HIP FRACTURE 160 0.0050
466 DERMATITIS BULLOUS 36 0.0050
467 HAEMORRHOIDS 97 0.0050
468 CHOKING 97 0.0050
469 MASS 69 0.0049
470 ORAL CANDIDIASIS 65 0.0049
471 DIPLOPIA 128 0.0049
472 BLOOD GLUCOSE INCREASED 928 0.0049
473 LOW DENSITY LIPOPROTEIN INCREASED 38 0.0049
474 EOSINOPHILIA 86 0.0049
475 MYOSITIS 44 0.0049
476 LOSS OF CONSCIOUSNESS 628 0.0049
477 FEBRILE NEUTROPENIA 324 0.0049
478 CARDIAC DISORDER 456 0.0049
479 HICCUPS 40 0.0049
480 PRODUCTIVE COUGH 232 0.0049
481 STEVENS-JOHNSON SYNDROME 108 0.0049
482 PRURITUS GENERALISED 105 0.0049
483 DECREASED APPETITE 1127 0.0048
484 FAECES DISCOLOURED 105 0.0048
485 FALL 1610 0.0048
486 BLOOD GLUCOSE DECREASED 232 0.0048
487 MYASTHENIA GRAVIS 39 0.0048
488 MUSCLE ATROPHY 61 0.0048
489 DIVERTICULITIS 133 0.0048
490 DYSPNOEA 2712 0.0048
491 BLOOD POTASSIUM DECREASED 144 0.0048
492 ADRENAL INSUFFICIENCY 58 0.0048
493 TENDONITIS 74 0.0048
494 APHASIA 144 0.0048
495 THROMBOCYTOPENIA 533 0.0048
496 RASH MACULO-PAPULAR 106 0.0048
497 ASTHENIA 1791 0.0048
498 LUNG INFECTION 74 0.0048
499 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 37 0.0048
500 VERTIGO 290 0.0048
501 PNEUMONIA 1535 0.0047
502 JOINT DISLOCATION 50 0.0047
503 RENAL PAIN 50 0.0047
504 RIB FRACTURE 97 0.0047
505 GAIT DISTURBANCE 902 0.0047
506 LETHARGY 271 0.0047
507 COLD SWEAT 83 0.0047
508 PANCYTOPENIA 263 0.0047
509 CEREBROVASCULAR ACCIDENT 797 0.0047
510 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 121 0.0047
511 RESPIRATORY DISORDER 140 0.0047
512 SEPSIS 521 0.0047
513 MUCOSAL INFLAMMATION 122 0.0047
514 WOUND INFECTION 51 0.0047
515 SKIN DISCOLOURATION 214 0.0047
516 PROSTATIC SPECIFIC ANTIGEN INCREASED 64 0.0046
517 HYPERTHYROIDISM 67 0.0046
518 HEART RATE DECREASED 162 0.0046
519 UNRESPONSIVE TO STIMULI 119 0.0046
520 BONE DISORDER 84 0.0046
521 CARDIOVASCULAR DISORDER 117 0.0046
522 HEART RATE IRREGULAR 104 0.0046
523 NEUTROPHIL COUNT INCREASED 47 0.0046
524 DIZZINESS 2288 0.0046
525 SCIATICA 73 0.0046
526 PYREXIA 1584 0.0046
527 FACIAL PARALYSIS 39 0.0046
528 LACERATION 43 0.0046
529 GASTRIC DISORDER 156 0.0045
530 DYSPHAGIA 431 0.0045
531 DRY THROAT 46 0.0045
532 SKIN LESION 124 0.0045
533 NO THERAPEUTIC RESPONSE 55 0.0045
534 SINUS TACHYCARDIA 64 0.0045
535 ESCHERICHIA INFECTION 37 0.0045
536 DIARRHOEA 2895 0.0045
537 FACIAL PAIN 40 0.0045
538 RESPIRATORY SYNCYTIAL VIRUS INFECTION 39 0.0045
539 LIP SWELLING 149 0.0045
540 INTESTINAL PERFORATION 50 0.0044
541 WEIGHT DECREASED 1241 0.0044
542 COUGH 1246 0.0044
543 INTERSTITIAL LUNG DISEASE 215 0.0044
544 ENCEPHALOPATHY 109 0.0044
545 CARPAL TUNNEL SYNDROME 62 0.0044
546 ILEUS 55 0.0044
547 BEDRIDDEN 58 0.0044
548 LIVER FUNCTION TEST ABNORMAL 128 0.0044
549 ULCER 70 0.0044
550 DYSPHONIA 257 0.0044
551 CHROMATURIA 99 0.0044
552 MUSCULOSKELETAL PAIN 229 0.0044
553 BURSITIS 53 0.0044
554 WOUND 122 0.0044
555 COLON CANCER 65 0.0044
556 SQUAMOUS CELL CARCINOMA 41 0.0044
557 HEPATIC FUNCTION ABNORMAL 162 0.0043
558 FOOT DEFORMITY 48 0.0043
559 VOMITING 2031 0.0043
560 ABDOMINAL PAIN 1002 0.0043
561 BALANCE DISORDER 372 0.0043
562 OSTEOPOROSIS 177 0.0043
563 RED BLOOD CELL COUNT DECREASED 123 0.0043
564 LOCALISED INFECTION 104 0.0043
565 LOCAL SWELLING 75 0.0043
566 BACTERAEMIA 51 0.0043
567 DEEP VEIN THROMBOSIS 278 0.0043
568 MYOCARDITIS 49 0.0043
569 LIMB INJURY 116 0.0043
570 METASTASES TO LIVER 75 0.0043
571 WRONG DRUG ADMINISTERED 38 0.0043
572 METASTASES TO LUNG 49 0.0042
573 MOVEMENT DISORDER 136 0.0042
574 DRUG ERUPTION 75 0.0042
575 PULMONARY FIBROSIS 81 0.0042
576 PLATELET COUNT DECREASED 450 0.0042
577 OSTEOPENIA 64 0.0042
578 ABDOMINAL PAIN UPPER 868 0.0042
579 INTERVERTEBRAL DISC DEGENERATION 39 0.0042
580 VISUAL ACUITY REDUCED 140 0.0042
581 PAIN IN EXTREMITY 1241 0.0042
582 CONVULSION 240 0.0042
583 NERVOUSNESS 219 0.0042
584 CARDIAC OPERATION 36 0.0042
585 NEOPLASM 48 0.0042
586 LIMB DISCOMFORT 129 0.0042
587 HALLUCINATION, VISUAL 88 0.0042
588 EAR PAIN 81 0.0042
589 PNEUMOTHORAX 66 0.0042
590 BRONCHITIS 308 0.0042
591 COORDINATION ABNORMAL 58 0.0042
592 INFLAMMATION 213 0.0041
593 DIZZINESS POSTURAL 40 0.0041
594 NECK PAIN 230 0.0041
595 NEURALGIA 100 0.0041
596 CYST 51 0.0041
597 BLOOD CALCIUM INCREASED 36 0.0041
598 LUNG DISORDER 201 0.0041
599 SWELLING FACE 266 0.0041
600 ANAPHYLACTIC SHOCK 105 0.0041
601 HEPATIC ENCEPHALOPATHY 38 0.0041
602 MUSCULOSKELETAL CHEST PAIN 63 0.0041
603 HEPATIC ENZYME INCREASED 277 0.0041
604 COLITIS 154 0.0041
605 POST PROCEDURAL COMPLICATION 78 0.0041
606 POISONING 51 0.0041
607 POOR VENOUS ACCESS 42 0.0041
608 TREATMENT NONCOMPLIANCE 222 0.0041
609 GENERALISED TONIC-CLONIC SEIZURE 67 0.0040
610 CYTOMEGALOVIRUS INFECTION 67 0.0040
611 FEELING HOT 247 0.0040
612 VIRAL INFECTION 134 0.0040
613 BODY TEMPERATURE INCREASED 82 0.0040
614 HAIR COLOUR CHANGES 50 0.0040
615 UPPER LIMB FRACTURE 80 0.0040
616 MUSCLE RIGIDITY 48 0.0040
617 PERITONITIS 83 0.0040
618 HEPATIC CYTOLYSIS 51 0.0040
619 THROMBOSIS 321 0.0040
620 HAEMATOCHEZIA 220 0.0040
621 FLUID OVERLOAD 58 0.0040
622 SKIN HAEMORRHAGE 59 0.0040
623 HYPERHIDROSIS 512 0.0040
624 ROTATOR CUFF SYNDROME 51 0.0040
625 RESPIRATORY ARREST 109 0.0040
626 BLOOD URINE PRESENT 75 0.0039
627 DRY MOUTH 320 0.0039
628 MEDICATION ERROR 219 0.0039
629 ORAL PAIN 88 0.0039
630 BACK PAIN 913 0.0039
631 PHARMACEUTICAL PRODUCT COMPLAINT 102 0.0039
632 ASPIRATION 43 0.0039
633 SLUGGISHNESS 40 0.0039
634 BLOOD THYROID STIMULATING HORMONE INCREASED 36 0.0039
635 INJURY 275 0.0039
636 STAPHYLOCOCCAL INFECTION 129 0.0039
637 MALAISE 1713 0.0039
638 PULMONARY EMBOLISM 371 0.0039
639 TOOTH FRACTURE 43 0.0039
640 JOINT RANGE OF MOTION DECREASED 52 0.0039
641 POST PROCEDURAL HAEMORRHAGE 45 0.0039
642 INFLUENZA 431 0.0039
643 SOMNOLENCE 774 0.0038
644 AMNESIA 250 0.0038
645 DERMATITIS ALLERGIC 48 0.0038
646 SEASONAL ALLERGY 54 0.0038
647 PHOTOSENSITIVITY REACTION 63 0.0038
648 FEELING COLD 106 0.0038
649 THIRST 68 0.0038
650 INITIAL INSOMNIA 39 0.0038
651 THERAPEUTIC PRODUCT EFFECT DECREASED 170 0.0038
652 NEPHROLITHIASIS 174 0.0038
653 GASTROOESOPHAGEAL REFLUX DISEASE 305 0.0038
654 ACTIVITIES OF DAILY LIVING IMPAIRED 75 0.0038
655 IMPAIRED HEALING 124 0.0038
656 HEART RATE INCREASED 374 0.0038
657 TOOTHACHE 68 0.0038
658 INJECTION SITE NODULE 41 0.0037
659 HEPATIC CIRRHOSIS 70 0.0037
660 CONTUSION 358 0.0037
661 POLLAKIURIA 155 0.0037
662 CHEST DISCOMFORT 380 0.0037
663 PNEUMONITIS 101 0.0037
664 ABDOMINAL DISTENSION 387 0.0037
665 ARTHRITIS 291 0.0037
666 EYELID OEDEMA 43 0.0037
667 DEMENTIA 103 0.0037
668 CLOSTRIDIUM DIFFICILE COLITIS 39 0.0037
669 TREMOR 610 0.0037
670 MYALGIA 616 0.0036
671 ANKLE FRACTURE 56 0.0036
672 TOXICITY TO VARIOUS AGENTS 609 0.0036
673 INTESTINAL OBSTRUCTION 136 0.0036
674 CRYING 131 0.0036
675 BONE PAIN 211 0.0036
676 WRIST FRACTURE 43 0.0036
677 BLINDNESS 146 0.0036
678 RESTLESSNESS 131 0.0036
679 HYPOAESTHESIA 535 0.0036
680 AGITATION 262 0.0036
681 BACK DISORDER 58 0.0036
682 TOOTH INFECTION 47 0.0036
683 RETCHING 76 0.0036
684 HYPERSOMNIA 102 0.0036
685 JOINT INJURY 76 0.0036
686 PARAESTHESIA 559 0.0035
687 CYSTITIS 113 0.0035
688 GASTROENTERITIS VIRAL 64 0.0035
689 BLOOD IRON DECREASED 42 0.0035
690 ABDOMINAL DISCOMFORT 593 0.0035
691 OSTEONECROSIS OF JAW 87 0.0035
692 CONDITION AGGRAVATED 1067 0.0035
693 WHEEZING 208 0.0035
694 FLATULENCE 198 0.0035
695 HALLUCINATION 263 0.0035
696 FOOT FRACTURE 66 0.0035
697 COVID-19 PNEUMONIA 41 0.0035
698 BREAST PAIN 37 0.0035
699 TOOTH DISORDER 77 0.0035
700 DEPRESSED MOOD 183 0.0035
701 ABSCESS 55 0.0034
702 PERIPHERAL SWELLING 529 0.0034
703 MACULAR DEGENERATION 41 0.0034
704 VISION BLURRED 471 0.0034
705 IMMUNE SYSTEM DISORDER 45 0.0034
706 MOBILITY DECREASED 245 0.0034
707 CHILLS 399 0.0034
708 UPPER RESPIRATORY TRACT INFECTION 157 0.0034
709 STOMATITIS 206 0.0034
710 SPINAL FRACTURE 68 0.0034
711 CONSTIPATION 740 0.0034
712 GASTRIC HAEMORRHAGE 39 0.0034
713 ARTHRALGIA 1408 0.0034
714 PRODUCT AVAILABILITY ISSUE 77 0.0034
715 BURNING SENSATION 237 0.0034
716 NEUROTOXICITY 59 0.0034
717 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 78 0.0033
718 DERMATITIS 70 0.0033
719 DECREASED ACTIVITY 36 0.0033
720 NAUSEA 2635 0.0033
721 ARTHROPATHY 185 0.0033
722 PARAESTHESIA ORAL 48 0.0033
723 RASH GENERALISED 86 0.0033
724 HEPATOCELLULAR INJURY 47 0.0033
725 PULMONARY ARTERIAL HYPERTENSION 48 0.0033
726 SKIN INFECTION 37 0.0033
727 FLUSHING 335 0.0033
728 SECRETION DISCHARGE 41 0.0033
729 DEPRESSION 742 0.0033
730 INJECTION SITE HAEMATOMA 47 0.0032
731 CONJUNCTIVITIS 60 0.0032
732 DRUG PRESCRIBING ERROR 62 0.0032
733 SWELLING 302 0.0032
734 DISTURBANCE IN ATTENTION 174 0.0032
735 APHONIA 45 0.0032
736 DELUSION 50 0.0032
737 HAIR TEXTURE ABNORMAL 43 0.0032
738 PARALYSIS 46 0.0032
739 PRESCRIBED UNDERDOSE 64 0.0032
740 INTRAOCULAR PRESSURE INCREASED 41 0.0032
741 MUSCULOSKELETAL DISCOMFORT 55 0.0032
742 EYE DISORDER 105 0.0032
743 PSYCHOMOTOR HYPERACTIVITY 53 0.0032
744 BLISTER 179 0.0032
745 LOWER LIMB FRACTURE 61 0.0032
746 WEIGHT INCREASED 710 0.0032
747 COGNITIVE DISORDER 148 0.0032
748 SEXUAL DYSFUNCTION 37 0.0032
749 DYSKINESIA 128 0.0031
750 MUSCLE TIGHTNESS 51 0.0031
751 EMOTIONAL DISORDER 97 0.0031
752 ACUTE MYELOID LEUKAEMIA 49 0.0031
753 GALLBLADDER DISORDER 56 0.0031
754 FATIGUE 2441 0.0031
755 SEDATION 82 0.0031
756 HYPERSENSITIVITY 579 0.0031
757 EAR INFECTION 83 0.0031
758 LABORATORY TEST ABNORMAL 92 0.0031
759 PALPITATIONS 364 0.0031
760 EPILEPSY 95 0.0031
761 MUSCLE SPASMS 569 0.0031
762 DYSPEPSIA 305 0.0031
763 EYE PAIN 174 0.0031
764 INTENTIONAL SELF-INJURY 62 0.0031
765 DYSGEUSIA 228 0.0031
766 HAEMORRHAGE 320 0.0031
767 DEAFNESS 80 0.0031
768 ANAPHYLACTIC REACTION 169 0.0031
769 GAIT INABILITY 102 0.0030
770 BONE MARROW FAILURE 62 0.0030
771 NERVOUS SYSTEM DISORDER 94 0.0030
772 PAIN 1849 0.0030
773 IMPAIRED GASTRIC EMPTYING 41 0.0030
774 MOUTH ULCERATION 63 0.0030
775 INCREASED APPETITE 57 0.0030
776 TINNITUS 137 0.0030
777 MEMORY IMPAIRMENT 409 0.0030
778 HEADACHE 1863 0.0030
779 DISEASE RECURRENCE 141 0.0030
780 SLEEP DISORDER 209 0.0030
781 JOINT SWELLING 357 0.0030
782 MUSCULOSKELETAL STIFFNESS 259 0.0030
783 KIDNEY INFECTION 58 0.0030
784 FUNGAL INFECTION 98 0.0029
785 ANXIETY 833 0.0029
786 DISEASE PROGRESSION 345 0.0029
787 INTENTIONAL OVERDOSE 187 0.0029
788 SKIN REACTION 41 0.0029
789 HERPES ZOSTER 167 0.0029
790 ACCIDENTAL OVERDOSE 106 0.0029
791 NEUTROPHIL COUNT DECREASED 118 0.0029
792 ERYTHEMA 595 0.0029
793 LIVER INJURY 71 0.0029
794 INSOMNIA 770 0.0029
795 NEUTROPENIA 393 0.0029
796 MYDRIASIS 37 0.0029
797 RHINORRHOEA 186 0.0029
798 ROAD TRAFFIC ACCIDENT 120 0.0029
799 DRUG INTOLERANCE 276 0.0029
800 INJECTION SITE INDURATION 37 0.0029
801 HYPOAESTHESIA ORAL 43 0.0028
802 VISUAL IMPAIRMENT 353 0.0028
803 NASAL CONGESTION 166 0.0028
804 DISCOMFORT 172 0.0028
805 UNEVALUABLE EVENT 213 0.0028
806 INFECTION 407 0.0028
807 RESTLESS LEGS SYNDROME 51 0.0028
808 SCAR 48 0.0028
809 COMPLETED SUICIDE 233 0.0028
810 WRONG TECHNIQUE IN DRUG USAGE PROCESS 101 0.0028
811 DRUG ADMINISTRATION ERROR 85 0.0028
812 HEAD DISCOMFORT 49 0.0028
813 LYMPHOPENIA 39 0.0028
814 POOR QUALITY SLEEP 59 0.0027
815 GASTROINTESTINAL DISORDER 245 0.0027
816 NIGHT SWEATS 88 0.0027
817 FEELING ABNORMAL 654 0.0027
818 SKIN DISORDER 91 0.0027
819 LACRIMATION INCREASED 82 0.0027
820 NEUROPATHY PERIPHERAL 258 0.0027
821 FEEDING DISORDER 55 0.0027
822 MYELODYSPLASTIC SYNDROME 39 0.0027
823 PRODUCT PRESCRIBING ERROR 64 0.0027
824 WHITE BLOOD CELL COUNT DECREASED 290 0.0027
825 TOOTH LOSS 55 0.0027
826 RESPIRATORY TRACT CONGESTION 42 0.0026
827 CYTOKINE RELEASE SYNDROME 53 0.0026
828 FIBROMYALGIA 64 0.0026
829 RASH MACULAR 92 0.0026
830 PRODUCT ADMINISTRATION ERROR 53 0.0026
831 RHEUMATOID ARTHRITIS 297 0.0026
832 PANIC ATTACK 95 0.0026
833 OROPHARYNGEAL PAIN 241 0.0026
834 SKIN CANCER 56 0.0026
835 NEOPLASM PROGRESSION 90 0.0026
836 HOT FLUSH 193 0.0026
837 JOINT STIFFNESS 67 0.0026
838 PRURITUS 981 0.0026
839 HYPOACUSIS 109 0.0025
840 FULL BLOOD COUNT DECREASED 51 0.0025
841 MUSCULOSKELETAL DISORDER 48 0.0025
842 RASH PRURITIC 136 0.0025
843 PAIN IN JAW 71 0.0025
844 PSYCHOTIC DISORDER 74 0.0025
845 NASOPHARYNGITIS 461 0.0025
846 PARANOIA 43 0.0025
847 MALIGNANT NEOPLASM PROGRESSION 255 0.0025
848 AGGRESSION 124 0.0025
849 MENTAL IMPAIRMENT 60 0.0025
850 MUSCLE TWITCHING 57 0.0025
851 SINUSITIS 253 0.0025
852 PROCEDURAL PAIN 68 0.0024
853 THERAPY NON-RESPONDER 110 0.0024
854 FREQUENT BOWEL MOVEMENTS 66 0.0024
855 RASH 1057 0.0024
856 ABNORMAL BEHAVIOUR 96 0.0024
857 EYE SWELLING 90 0.0024
858 THINKING ABNORMAL 45 0.0024
859 SEIZURE 277 0.0024
860 LYMPHOMA 37 0.0024
861 SUICIDE ATTEMPT 144 0.0024
862 MANIA 39 0.0024
863 ASTHMA 267 0.0024
864 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 168 0.0024
865 INTENTIONAL DOSE OMISSION 67 0.0023
866 LYMPHADENOPATHY 83 0.0023
867 NIGHTMARE 81 0.0023
868 IRRITABILITY 140 0.0023
869 DRY EYE 116 0.0023
870 PRODUCT USE ISSUE 433 0.0023
871 DRUG RESISTANCE 59 0.0023
872 INTENTIONAL DRUG MISUSE 48 0.0023
873 ABDOMINAL PAIN LOWER 58 0.0023
874 ABNORMAL DREAMS 63 0.0023
875 HERNIA 44 0.0023
876 URTICARIA 380 0.0023
877 MIDDLE INSOMNIA 42 0.0022
878 SNEEZING 50 0.0022
879 INTENTIONAL PRODUCT MISUSE 195 0.0022
880 MOOD ALTERED 60 0.0022
881 GLOSSODYNIA 49 0.0022
882 RASH PAPULAR 49 0.0022
883 THROAT TIGHTNESS 59 0.0022
884 EXTRAPYRAMIDAL DISORDER 54 0.0022
885 WITHDRAWAL SYNDROME 91 0.0022
886 LUNG NEOPLASM MALIGNANT 89 0.0022
887 MENTAL DISORDER 94 0.0022
888 SKIN EXFOLIATION 182 0.0022
889 RASH ERYTHEMATOUS 103 0.0022
890 OCULAR HYPERAEMIA 102 0.0021
891 DRUG EFFECT INCOMPLETE 77 0.0021
892 CLOSTRIDIUM DIFFICILE INFECTION 46 0.0021
893 THERAPEUTIC RESPONSE UNEXPECTED 94 0.0021
894 PELVIC PAIN 38 0.0021
895 SYSTEMIC LUPUS ERYTHEMATOSUS 74 0.0021
896 INFUSION RELATED REACTION 138 0.0021
897 THERAPEUTIC RESPONSE DECREASED 126 0.0021
898 ERUCTATION 40 0.0021
899 OFF LABEL USE 1807 0.0021
900 ORAL HERPES 40 0.0020
901 PSORIASIS 267 0.0020
902 ALOPECIA 394 0.0020
903 SURGERY 117 0.0020
904 SKIN FISSURES 39 0.0020
905 DRUG EFFECT DECREASED 107 0.0020
906 DRUG INEFFECTIVE 2613 0.0020
907 ANGER 67 0.0020
908 INFLUENZA LIKE ILLNESS 163 0.0020
909 LOWER RESPIRATORY TRACT INFECTION 90 0.0020
910 ILL-DEFINED DISORDER 120 0.0020
911 PHOTOPHOBIA 37 0.0020
912 EMOTIONAL DISTRESS 237 0.0020
913 LIVER FUNCTION TEST INCREASED 42 0.0020
914 DRUG DOSE OMISSION 323 0.0020
915 INCORRECT PRODUCT ADMINISTRATION DURATION 42 0.0019
916 TASTE DISORDER 39 0.0019
917 THROAT IRRITATION 86 0.0019
918 MOOD SWINGS 61 0.0019
919 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 105 0.0019
920 IRRITABLE BOWEL SYNDROME 41 0.0019
921 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 91 0.0019
922 SUICIDAL IDEATION 172 0.0019
923 SINUS DISORDER 37 0.0019
924 INCORRECT DRUG ADMINISTRATION DURATION 52 0.0018
925 INTENTIONAL PRODUCT USE ISSUE 161 0.0018
926 PREMATURE BABY 55 0.0018
927 OVERDOSE 394 0.0018
928 COVID-19 318 0.0018
929 EYE IRRITATION 103 0.0018
930 ECZEMA 93 0.0018
931 OSTEONECROSIS 57 0.0017
932 PRODUCT SUBSTITUTION ISSUE 99 0.0017
933 PRODUCT DOSE OMISSION 111 0.0017
934 PANCREATIC CARCINOMA 49 0.0017
935 MULTIPLE SCLEROSIS 79 0.0017
936 INJECTION SITE MASS 61 0.0016
937 UNDERDOSE 120 0.0016
938 EYE PRURITUS 55 0.0016
939 THERAPY CESSATION 83 0.0016
940 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 287 0.0016
941 PRODUCT QUALITY ISSUE 216 0.0016
942 DRY SKIN 211 0.0016
943 PRODUCT USE IN UNAPPROVED INDICATION 389 0.0016
944 PSORIATIC ARTHROPATHY 63 0.0016
945 BONE DENSITY DECREASED 48 0.0015
946 DRUG EXPOSURE DURING PREGNANCY 51 0.0015
947 COLITIS ULCERATIVE 65 0.0015
948 PLASMA CELL MYELOMA 56 0.0014
949 INJECTION SITE HAEMORRHAGE 113 0.0014
950 EXPIRED PRODUCT ADMINISTERED 47 0.0014
951 TARDIVE DYSKINESIA 39 0.0014
952 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 98 0.0014
953 ILLNESS 141 0.0014
954 INJECTION SITE PRURITUS 91 0.0014
955 INCORRECT DOSE ADMINISTERED 310 0.0014
956 DEATH 1134 0.0013
957 FOETAL EXPOSURE DURING PREGNANCY 104 0.0013
958 INJECTION SITE PAIN 392 0.0013
959 THERAPY INTERRUPTED 91 0.0013
960 INJECTION SITE SWELLING 96 0.0013
961 VAGINAL HAEMORRHAGE 54 0.0012
962 NEOPLASM MALIGNANT 83 0.0012
963 GYNAECOMASTIA 37 0.0012
964 MIGRAINE 114 0.0012
965 PRODUCT DOSE OMISSION ISSUE 351 0.0012
966 INJECTION SITE ERYTHEMA 143 0.0012
967 DEVICE MALFUNCTION 80 0.0011
968 DRUG ABUSE 94 0.0011
969 PROSTATE CANCER 89 0.0011
970 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 220 0.0011
971 BREAST CANCER 101 0.0011
972 MULTIPLE SCLEROSIS RELAPSE 74 0.0011
973 HOSPITALISATION 164 0.0011
974 ADVERSE EVENT 96 0.0010
975 INJECTION SITE BRUISING 82 0.0010
976 ADVERSE DRUG REACTION 92 0.0010
977 MATERNAL EXPOSURE DURING PREGNANCY 91 0.0010
978 INJECTION SITE REACTION 67 0.0010
979 DEVICE DISLOCATION 41 0.0009
980 SKIN BURNING SENSATION 66 0.0009
981 ABORTION SPONTANEOUS 36 0.0009
982 SKIN IRRITATION 41 0.0009
983 EXPOSURE DURING PREGNANCY 55 0.0009
984 DEVICE ISSUE 79 0.0009
985 RENAL CANCER 41 0.0009
986 BLADDER CANCER 50 0.0008
987 ACNE 63 0.0008
988 NO ADVERSE EVENT 150 0.0008
989 DRUG WITHDRAWAL SYNDROME 67 0.0008
990 TREATMENT FAILURE 57 0.0007
991 PRODUCT STORAGE ERROR 51 0.0006
992 DRUG DEPENDENCE 78 0.0005
993 ACCIDENTAL EXPOSURE TO PRODUCT 38 0.0004